Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 90

1.

Transcriptional and posttranscriptional regulation of the locus of enterocyte effacement in Escherichia albertii.

Egan M, Critelli B, Cleary SP, Marino M, Upreti C, Kalman D, Bhatt S.

Microb Pathog. 2019 Oct;135:103643. doi: 10.1016/j.micpath.2019.103643. Epub 2019 Jul 20.

PMID:
31336143
2.

Early-onset gastric cancer is a distinct disease with worrisome trends and oncogenic features.

Bergquist JR, Leiting JL, Habermann EB, Cleary SP, Kendrick ML, Smoot RL, Nagorney DM, Truty MJ, Grotz TE.

Surgery. 2019 Oct;166(4):547-555. doi: 10.1016/j.surg.2019.04.036. Epub 2019 Jul 20.

PMID:
31331685
3.

Survival and prognostic factors in patients with pancreatic squamous cell carcinoma.

Tella SH, Kommalapati A, Yadav S, Bergquist JR, Truty MJ, Durgin L, Ma WW, Cleary SP, McWilliams RR, Mahipal A.

Eur J Surg Oncol. 2019 Sep;45(9):1700-1705. doi: 10.1016/j.ejso.2019.05.011. Epub 2019 May 15.

PMID:
31118133
4.

Factors Predicting Response, Perioperative Outcomes, and Survival Following Total Neoadjuvant Therapy for Borderline/Locally Advanced Pancreatic Cancer.

Truty MJ, Kendrick ML, Nagorney DM, Smoot RL, Cleary SP, Graham RP, Goenka AH, Hallemeier CL, Haddock MG, Harmsen WS, Mahipal A, McWilliams RR, Halfdanarson TR, Grothey AF.

Ann Surg. 2019 Apr 5. doi: 10.1097/SLA.0000000000003284. [Epub ahead of print]

PMID:
30946090
5.

Minimally Invasive Management of Secondary Liver Cancer.

Yohanathan L, Cleary SP.

Surg Oncol Clin N Am. 2019 Apr;28(2):229-241. doi: 10.1016/j.soc.2018.11.003. Epub 2019 Jan 7. Review.

PMID:
30851825
6.

Management and surveillance of non-functional pancreatic neuroendocrine tumours: Retrospective review.

Yohanathan L, Dossa F, St Germain AT, Golbafian F, Moulton CA, McGilvray ID, Greig PD, Serra S, Wei AC, Jhaveri KS, Gallinger S, Cleary SP.

Pancreatology. 2019 Mar;19(2):360-366. doi: 10.1016/j.pan.2019.02.008. Epub 2019 Feb 18.

PMID:
30803874
7.

Effect of portal vein embolization on treatment plan prior to major hepatectomy for hepatocellular carcinoma.

Loveday BPT, Jaberi A, Moulton CA, Wei AC, Gallinger S, Beecroft R, Fischer S, Ghanekar A, McGilvray I, Sapisochin G, Greig PD, Tan K, Cleary SP.

HPB (Oxford). 2019 Aug;21(8):1072-1078. doi: 10.1016/j.hpb.2018.12.009. Epub 2019 Feb 20.

PMID:
30797726
8.

Liberating Native Mass Spectrometry from Dependence on Volatile Salt Buffers by Use of Gábor Transform.

Cleary SP, Prell JS.

Chemphyschem. 2019 Feb 18;20(4):519-523. doi: 10.1002/cphc.201900022. Epub 2019 Jan 30.

PMID:
30618194
9.

Outcomes of radiofrequency ablation as first-line therapy for hepatocellular carcinoma less than 3 cm in potentially transplantable patients.

Doyle A, Gorgen A, Muaddi H, Aravinthan AD, Issachar A, Mironov O, Zhang W, Kachura J, Beecroft R, Cleary SP, Ghanekar A, Greig PD, McGilvray ID, Selzner M, Cattral MS, Grant DR, Lilly LB, Selzner N, Renner EL, Sherman M, Sapisochin G.

J Hepatol. 2019 May;70(5):866-873. doi: 10.1016/j.jhep.2018.12.027. Epub 2019 Jan 5.

PMID:
30615906
10.

Cost Effectiveness of Hepatocellular Carcinoma Surveillance After a Sustained Virologic Response to Therapy in Patients With Hepatitis C Virus Infection and Advanced Fibrosis.

Farhang Zangneh H, Wong WWL, Sander B, Bell CM, Mumtaz K, Kowgier M, van der Meer AJ, Cleary SP, Janssen HLA, Chan KKW, Feld JJ.

Clin Gastroenterol Hepatol. 2019 Aug;17(9):1840-1849.e16. doi: 10.1016/j.cgh.2018.12.018. Epub 2018 Dec 20.

PMID:
30580095
11.

Renal outcomes following left renal vein harvest for venous reconstruction during pancreas and liver surgery.

Loveday BPT, Dib MJ, Sequeira S, Alotaiby N, Visser R, Barbas AS, Wei AC, Cleary SP, Moulton CA, Gallinger S, Greig PD, McGilvray ID.

HPB (Oxford). 2019 Jan;21(1):114-120. doi: 10.1016/j.hpb.2018.07.015. Epub 2018 Oct 13.

PMID:
30322713
12.

Synchronous colorectal liver metastases: a national survey of surgeon opinions on simultaneous resection and multidisciplinary cooperation.

Howard C, Clements TW, Edwards JP, MacLean AR, Buie WD, Dixon E, Grondin SC, Gomes A, McColl M, Cleary SP, Jayaraman S, Daigle R, Ball CG.

Hepatobiliary Surg Nutr. 2018 Aug;7(4):242-250. doi: 10.21037/hbsn.2017.12.01.

13.

Assessing tools for management of noncolorectal nonneuroendocrine liver metastases: External validation of a prognostic model.

Tsang ME, Mahar AL, Martel G, Cleary SP, Nanji S, Ouellet JF, Hernandez-Alejandro R, Wei AC, Hallet J; Members of the Canadian Noncolorectal Nonneuroendocrine Liver Metastases Study Group.

J Surg Oncol. 2018 Nov;118(6):1006-1011. doi: 10.1002/jso.25228. Epub 2018 Sep 9.

PMID:
30196563
14.

Extracting Charge and Mass Information from Highly Congested Mass Spectra Using Fourier-Domain Harmonics.

Cleary SP, Li H, Bagal D, Loo JA, Campuzano IDG, Prell JS.

J Am Soc Mass Spectrom. 2018 Oct;29(10):2067-2080. doi: 10.1007/s13361-018-2018-7. Epub 2018 Jul 12.

15.

A Review of Circulating Tumor DNA in Hepatobiliary Malignancies.

Mody K, Cleary SP.

Front Oncol. 2018 Jun 11;8:212. doi: 10.3389/fonc.2018.00212. eCollection 2018. Review.

16.

Large Hepatic Mass in an Adolescent Male.

Shah SM, Kamboj AK, Cleary SP.

Gastroenterology. 2018 Oct;155(4):e9-e10. doi: 10.1053/j.gastro.2018.05.046. Epub 2018 Jun 5. No abstract available.

PMID:
29883582
17.

Indications and Perioperative Outcomes for Pancreatectomy with Arterial Resection.

Tee MC, Krajewski AC, Groeschl RT, Farnell MB, Nagorney DM, Kendrick ML, Cleary SP, Smoot RL, Croome KP, Truty MJ.

J Am Coll Surg. 2018 Aug;227(2):255-269. doi: 10.1016/j.jamcollsurg.2018.05.001. Epub 2018 May 9.

PMID:
29752997
18.

Minimally Invasive Liver Surgery: Has it Achieved the Standard of Care?

Cleary SP.

Ann Surg Oncol. 2018 May;25(5):1105-1107. doi: 10.1245/s10434-018-6380-2. Epub 2018 Feb 21. No abstract available.

PMID:
29468605
19.

Liver Transplantation is Equally Effective as a Salvage Therapy for Patients with Hepatocellular Carcinoma Recurrence Following Radiofrequency Ablation or Liver Resection with Curative Intent.

Muaddi H, Al-Adra DP, Beecroft R, Ghanekar A, Moulton CA, Doyle A, Selzner M, Wei A, McGilvray ID, Gallinger S, Grant DR, Cattral MS, Greig PD, Kachura J, Cleary SP, Sapisochin G.

Ann Surg Oncol. 2018 Apr;25(4):991-999. doi: 10.1245/s10434-017-6329-x. Epub 2018 Jan 11.

PMID:
29327179
20.

Implementation of prospective, surgeon-driven, risk-based pathway for pancreatoduodenectomy results in improved clinical outcomes and first year cost savings of $1 million.

Shubert CR, Kendrick ML, Habermann EB, Glasgow AE, Borah BJ, Moriarty JP, Cleary SP, Smoot RL, Farnell MB, Nagorney DM, Truty MJ, Que FG.

Surgery. 2018 Mar;163(3):495-502. doi: 10.1016/j.surg.2017.10.022. Epub 2017 Dec 21.

PMID:
29275974
21.

Two BRM promoter polymorphisms predict poor survival in patients with hepatocellular carcinoma.

Pasic I, Wong KM, Lee JJ, Espin-Garcia O, Brhane Y, Cheng D, Chen Z, Patel D, Brown C, Bucur R, Reisman D, Knox JJ, Xu W, Hung RJ, Liu G, Cleary SP.

Mol Carcinog. 2018 Jan;57(1):106-113. doi: 10.1002/mc.22736. Epub 2017 Oct 9.

PMID:
28892201
22.

The economics of recovery after pancreatic surgery: detailed cost minimization analysis of an enhanced recovery program.

Kagedan DJ, Devitt KS, Tremblay St-Germain A, Ramjaun A, Cleary SP, Wei AC.

HPB (Oxford). 2017 Nov;19(11):1026-1033. doi: 10.1016/j.hpb.2017.07.013. Epub 2017 Sep 1.

23.

Effect of Pancreatic Fistula on Recurrence and Long-Term Prognosis of Periampullary Adenocarcinomas after Pancreaticoduodenectomy.

Serrano PE, Kim D, Kim PT, Greig PD, Moulton CA, Gallinger S, Wei AC, Cleary SP.

Am Surg. 2016 Dec 1;82(12):1187-1195.

PMID:
28234183
24.

Erratum: A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns.

Notta F, Chan-Seng-Yue M, Lemire M, Li Y, Wilson GW, Connor AA, Denroche RE, Liang SB, Brown AM, Kim JC, Wang T, Simpson JT, Beck T, Borgida A, Buchner N, Chadwick D, Hafezi-Bakhtiari S, Dick JE, Heisler L, Hollingsworth MA, Ibrahimov E, Jang GH, Johns J, Jorgensen LG, Law C, Ludkovski O, Lungu I, Ng K, Pasternack D, Petersen GM, Shlush LI, Timms L, Tsao MS, Wilson JM, Yung CK, Zogopoulos G, Bartlett JM, Alexandrov LB, Real FX, Cleary SP, Roehrl MH, McPherson JD, Stein LD, Hudson TJ, Campbell PJ, Gallinger S.

Nature. 2017 Feb 2;542(7639):124. doi: 10.1038/nature20164. Epub 2016 Nov 16. No abstract available.

PMID:
27851734
25.

The comparative costs of laparoscopic and open liver resection: a report for the 2nd International Consensus Conference on Laparoscopic Liver Resection.

Cleary SP, Han HS, Yamamoto M, Wakabayashi G, Asbun HJ.

Surg Endosc. 2016 Nov;30(11):4691-4696. Epub 2016 Mar 1. Review.

PMID:
26932551
26.

A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns.

Notta F, Chan-Seng-Yue M, Lemire M, Li Y, Wilson GW, Connor AA, Denroche RE, Liang SB, Brown AM, Kim JC, Wang T, Simpson JT, Beck T, Borgida A, Buchner N, Chadwick D, Hafezi-Bakhtiari S, Dick JE, Heisler L, Hollingsworth MA, Ibrahimov E, Jang GH, Johns J, Jorgensen LG, Law C, Ludkovski O, Lungu I, Ng K, Pasternack D, Petersen GM, Shlush LI, Timms L, Tsao MS, Wilson JM, Yung CK, Zogopoulos G, Bartlett JM, Alexandrov LB, Real FX, Cleary SP, Roehrl MH, McPherson JD, Stein LD, Hudson TJ, Campbell PJ, Gallinger S.

Nature. 2016 Oct 20;538(7625):378-382. doi: 10.1038/nature19823. Epub 2016 Oct 12. Erratum in: Nature. 2017 Feb 2;542(7639):124.

27.

Trends in port-site metastasis after laparoscopic resection of incidental gallbladder cancer: A systematic review.

Berger-Richardson D, Chesney TR, Englesakis M, Govindarajan A, Cleary SP, Swallow CJ.

Surgery. 2017 Mar;161(3):618-627. doi: 10.1016/j.surg.2016.08.007. Epub 2016 Oct 13. Review.

PMID:
27743715
28.

BRM polymorphisms, pancreatic cancer risk and survival.

Segedi M, Anderson LN, Espin-Garcia O, Borgida A, Bianco T, Cheng D, Chen Z, Patel D, Brown MC, Xu W, Reisman D, Gallinger S, Cotterchio M, Hung R, Liu G, Cleary SP.

Int J Cancer. 2016 Dec 1;139(11):2474-81. doi: 10.1002/ijc.30369. Epub 2016 Aug 18.

29.

Comparison of Clinical Outcomes following Glue versus Polyvinyl Alcohol Portal Vein Embolization for Hypertrophy of the Future Liver Remnant prior to Right Hepatectomy.

Jaberi A, Toor SS, Rajan DK, Mironov O, Kachura JR, Cleary SP, Smoot R, Tremblay St-Germain A, Tan K.

J Vasc Interv Radiol. 2016 Dec;27(12):1897-1905.e1. doi: 10.1016/j.jvir.2016.05.023. Epub 2016 Jul 18.

PMID:
27435682
30.

Fourier Analysis Method for Analyzing Highly Congested Mass Spectra of Ion Populations with Repeated Subunits.

Cleary SP, Thompson AM, Prell JS.

Anal Chem. 2016 Jun 21;88(12):6205-13. doi: 10.1021/acs.analchem.6b01088. Epub 2016 Jun 1.

PMID:
27213759
31.

Risk of extracolonic cancers for people with biallelic and monoallelic mutations in MUTYH.

Win AK, Reece JC, Dowty JG, Buchanan DD, Clendenning M, Rosty C, Southey MC, Young JP, Cleary SP, Kim H, Cotterchio M, Macrae FA, Tucker KM, Baron JA, Burnett T, Le Marchand L, Casey G, Haile RW, Newcomb PA, Thibodeau SN, Hopper JL, Gallinger S, Winship IM, Lindor NM, Jenkins MA.

Int J Cancer. 2016 Oct 1;139(7):1557-63. doi: 10.1002/ijc.30197. Epub 2016 Jun 2. Erratum in: Int J Cancer. 2017 Dec 15;141(12 ):E7.

32.

The extended Toronto criteria for liver transplantation in patients with hepatocellular carcinoma: A prospective validation study.

Sapisochin G, Goldaracena N, Laurence JM, Dib M, Barbas A, Ghanekar A, Cleary SP, Lilly L, Cattral MS, Marquez M, Selzner M, Renner E, Selzner N, McGilvray ID, Greig PD, Grant DR.

Hepatology. 2016 Dec;64(6):2077-2088. doi: 10.1002/hep.28643. Epub 2016 Jun 30.

PMID:
27178646
33.

Survival Following Resection of Intra- and Extra-Hepatic Metastases from Colorectal Cancer: A Phase II Trial.

Wei AC, Coburn NG, Devitt KS, Serrano PE, Moulton CA, Cleary SP, Law C, Moore MJ, Gallinger S.

Ann Surg Oncol. 2016 Aug;23(8):2644-51. doi: 10.1245/s10434-016-5189-0. Epub 2016 Mar 30.

PMID:
27027312
34.

The Toronto General Hospital Transitional Pain Service: development and implementation of a multidisciplinary program to prevent chronic postsurgical pain.

Katz J, Weinrib A, Fashler SR, Katznelzon R, Shah BR, Ladak SS, Jiang J, Li Q, McMillan K, Santa Mina D, Wentlandt K, McRae K, Tamir D, Lyn S, de Perrot M, Rao V, Grant D, Roche-Nagle G, Cleary SP, Hofer SO, Gilbert R, Wijeysundera D, Ritvo P, Janmohamed T, O'Leary G, Clarke H.

J Pain Res. 2015 Oct 12;8:695-702. doi: 10.2147/JPR.S91924. eCollection 2015.

35.

Vitamin D and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Case-Control Consortium.

Waterhouse M, Risch HA, Bosetti C, Anderson KE, Petersen GM, Bamlet WR, Cotterchio M, Cleary SP, Ibiebele TI, La Vecchia C, Skinner HG, Strayer L, Bracci PM, Maisonneuve P, Bueno-de-Mesquita HB, Zatoński W, Lu L, Yu H, Janik-Koncewicz K, Polesel J, Serraino D, Neale RE; Pancreatic Cancer Case-Control Consortium (PanC4).

Ann Oncol. 2016 Jan;27(1):208. doi: 10.1093/annonc/mdv480. Epub 2015 Oct 13. No abstract available.

36.

The effect of 5-fluorouracil/leucovorin chemotherapy on CpG methylation, or the confounding role of leukocyte heterogeneity: An illustration.

Lemire M, Zaidi SH, Zanke BW, Gallinger S, Hudson TJ, Cleary SP.

Genomics. 2015 Dec;106(6):340-7. doi: 10.1016/j.ygeno.2015.09.003. Epub 2015 Sep 11.

37.

Risk of colorectal cancer for people with a mutation in both a MUTYH and a DNA mismatch repair gene.

Win AK, Reece JC, Buchanan DD, Clendenning M, Young JP, Cleary SP, Kim H, Cotterchio M, Dowty JG, MacInnis RJ, Tucker KM, Winship IM, Macrae FA, Burnett T, Le Marchand L, Casey G, Haile RW, Newcomb PA, Thibodeau SN, Lindor NM, Hopper JL, Gallinger S, Jenkins MA.

Fam Cancer. 2015 Dec;14(4):575-83. doi: 10.1007/s10689-015-9824-x.

38.

Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer.

Childs EJ, Mocci E, Campa D, Bracci PM, Gallinger S, Goggins M, Li D, Neale RE, Olson SH, Scelo G, Amundadottir LT, Bamlet WR, Bijlsma MF, Blackford A, Borges M, Brennan P, Brenner H, Bueno-de-Mesquita HB, Canzian F, Capurso G, Cavestro GM, Chaffee KG, Chanock SJ, Cleary SP, Cotterchio M, Foretova L, Fuchs C, Funel N, Gazouli M, Hassan M, Herman JM, Holcatova I, Holly EA, Hoover RN, Hung RJ, Janout V, Key TJ, Kupcinskas J, Kurtz RC, Landi S, Lu L, Malecka-Panas E, Mambrini A, Mohelnikova-Duchonova B, Neoptolemos JP, Oberg AL, Orlow I, Pasquali C, Pezzilli R, Rizzato C, Saldia A, Scarpa A, Stolzenberg-Solomon RZ, Strobel O, Tavano F, Vashist YK, Vodicka P, Wolpin BM, Yu H, Petersen GM, Risch HA, Klein AP.

Nat Genet. 2015 Aug;47(8):911-6. doi: 10.1038/ng.3341. Epub 2015 Jun 22.

39.

Association between body mass index and mortality for colorectal cancer survivors: overall and by tumor molecular phenotype.

Campbell PT, Newton CC, Newcomb PA, Phipps AI, Ahnen DJ, Baron JA, Buchanan DD, Casey G, Cleary SP, Cotterchio M, Farris AB, Figueiredo JC, Gallinger S, Green RC, Haile RW, Hopper JL, Jenkins MA, Le Marchand L, Makar KW, McLaughlin JR, Potter JD, Renehan AG, Sinicrope FA, Thibodeau SN, Ulrich CM, Win AK, Lindor NM, Limburg PJ.

Cancer Epidemiol Biomarkers Prev. 2015 Aug;24(8):1229-38. doi: 10.1158/1055-9965.EPI-15-0094. Epub 2015 Jun 2.

40.

Hepato-pancreato-biliary surgery workforce in Canada.

Edwards JP, Bressan A, Dharampal N, Grondin SC, Datta I, Dixon E, Cleary SP, Barkun JS, Butte JM, Ball CG.

Can J Surg. 2015 Jun;58(3):212-5.

41.

Vitamin D and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Case-Control Consortium.

Waterhouse M, Risch HA, Bosetti C, Anderson KE, Petersen GM, Bamlet WR, Cotterchio M, Cleary SP, Ibiebele TI, La Vecchia C, Skinner HG, Strayer L, Bracci PM, Maisonneuve P, Bueno-de-Mesquita HB, Zaton Ski W, Lu L, Yu H, Janik-Koncewicz K, Polesel J, Serraino D, Neale RE; Pancreatic Cancer Case–Control Consortium (PanC4).

Ann Oncol. 2015 Aug;26(8):1776-83. doi: 10.1093/annonc/mdv236. Epub 2015 May 14. Erratum in: Ann Oncol. 2016 Jan;27(1):208. Polesel, J [added]; Serraino, D [added].

42.

TERT gene harbors multiple variants associated with pancreatic cancer susceptibility.

Campa D, Rizzato C, Stolzenberg-Solomon R, Pacetti P, Vodicka P, Cleary SP, Capurso G, Bueno-de-Mesquita HB, Werner J, Gazouli M, Butterbach K, Ivanauskas A, Giese N, Petersen GM, Fogar P, Wang Z, Bassi C, Ryska M, Theodoropoulos GE, Kooperberg C, Li D, Greenhalf W, Pasquali C, Hackert T, Fuchs CS, Mohelnikova-Duchonova B, Sperti C, Funel N, Dieffenbach AK, Wareham NJ, Buring J, Holcátová I, Costello E, Zambon CF, Kupcinskas J, Risch HA, Kraft P, Bracci PM, Pezzilli R, Olson SH, Sesso HD, Hartge P, Strobel O, Małecka-Panas E, Visvanathan K, Arslan AA, Pedrazzoli S, Souček P, Gioffreda D, Key TJ, Talar-Wojnarowska R, Scarpa A, Mambrini A, Jacobs EJ, Jamroziak K, Klein A, Tavano F, Bambi F, Landi S, Austin MA, Vodickova L, Brenner H, Chanock SJ, Delle Fave G, Piepoli A, Cantore M, Zheng W, Wolpin BM, Amundadottir LT, Canzian F.

Int J Cancer. 2015 Nov 1;137(9):2175-83. doi: 10.1002/ijc.29590. Epub 2015 Jun 19.

43.

Localized and systemic approaches to treating hepatocellular carcinoma.

Knox JJ, Cleary SP, Dawson LA.

J Clin Oncol. 2015 Jun 1;33(16):1835-44. doi: 10.1200/JCO.2014.60.1153. Epub 2015 Apr 27. Review. No abstract available.

PMID:
25918289
44.

Association between alcohol consumption and pancreatic cancer risk: a case-control study.

Rahman F, Cotterchio M, Cleary SP, Gallinger S.

PLoS One. 2015 Apr 9;10(4):e0124489. doi: 10.1371/journal.pone.0124489. eCollection 2015.

45.

Canadian practice patterns for pancreaticoduodenectomy.

Cyr DP, Truong JL, Lam-McCulloch J, Cleary SP, Karanicolas PJ.

Can J Surg. 2015 Apr;58(2):121-7.

46.

What is the best technique in parenchymal transection in laparoscopic liver resection? Comprehensive review for the clinical question on the 2nd International Consensus Conference on Laparoscopic Liver Resection.

Otsuka Y, Kaneko H, Cleary SP, Buell JF, Cai X, Wakabayashi G.

J Hepatobiliary Pancreat Sci. 2015 May;22(5):363-70. doi: 10.1002/jhbp.216. Epub 2015 Jan 29. Review.

PMID:
25631462
47.

Risk factors associated with recurrence in patients with solid pseudopapillary tumors of the pancreas.

Serrano PE, Serra S, Al-Ali H, Gallinger S, Greig PD, McGilvray ID, Moulton CA, Wei AC, Cleary SP.

JOP. 2014 Nov 28;15(6):561-8. doi: 10.6092/1590-8577/2423.

48.

Improved long-term outcomes after resection of pancreatic adenocarcinoma: a comparison between two time periods.

Serrano PE, Cleary SP, Dhani N, Kim PT, Greig PD, Leung K, Moulton CA, Gallinger S, Wei AC.

Ann Surg Oncol. 2015 Apr;22(4):1160-7. doi: 10.1245/s10434-014-4196-2. Epub 2014 Oct 28.

PMID:
25348784
49.

Laparoscopic versus open liver resection for hepatocellular carcinoma at a North-American Centre: a 2-to-1 matched pair analysis.

Lee JJ, Conneely JB, Smoot RL, Gallinger S, Greig PD, Moulton CA, Wei A, McGilvray I, Cleary SP.

HPB (Oxford). 2015 Apr;17(4):304-10. doi: 10.1111/hpb.12342. Epub 2014 Oct 9.

50.

Consensus and controversy in hepatic surgery: a survey of Canadian surgeons.

Truong JL, Cyr DP, Lam-McCulloch J, Cleary SP, Karanicolas PJ.

J Surg Oncol. 2014 Dec;110(8):947-51. doi: 10.1002/jso.23748. Epub 2014 Aug 22.

PMID:
25154605

Supplemental Content

Loading ...
Support Center